Larimar Therapeutics (LRMR) Other Gross PP&E Adjustments: 2013-2020
Historic Other Gross PP&E Adjustments for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to -$4.0 million.
- Larimar Therapeutics' Other Gross PP&E Adjustments rose 43.93% to -$4.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$8.7 million, marking a year-over-year increase of 54.92%. This contributed to the annual value of $29,000 for FY2019, which is 100.84% up from last year.
- Larimar Therapeutics' Other Gross PP&E Adjustments amounted to -$4.0 million in Q3 2020, which was down 3.93% from -$3.9 million recorded in Q2 2020.
- In the past 5 years, Larimar Therapeutics' Other Gross PP&E Adjustments registered a high of $29,000 during Q4 2019, and its lowest value of -$7.3 million during Q2 2019.
- Its 3-year average for Other Gross PP&E Adjustments is -$2.7 million, with a median of -$1.4 million in 2019.
- Examining YoY changes over the last 5 years, Larimar Therapeutics' Other Gross PP&E Adjustments showed a top increase of 100.84% in 2019 and a maximum decrease of 2,373.10% in 2019.
- Quarterly analysis of 5 years shows Larimar Therapeutics' Other Gross PP&E Adjustments stood at -$5.0 million in 2016, then climbed by 10.19% to -$4.5 million in 2017, then increased by 23.96% to -$3.4 million in 2018, then surged by 100.84% to $29,000 in 2019, then soared by 43.93% to -$4.0 million in 2020.
- Its last three reported values are -$4.0 million in Q3 2020, -$3.9 million for Q2 2020, and -$852,000 during Q1 2020.